HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacological characterization of human kappa/mu opioid receptor chimeras that retain high affinity for dynorphin A.

Abstract
Arylacetamide analgesics that stimulate kappa opioid receptors in the central nervous system mediate dysphoria and psychosis as well as analgesia. However, the naturally occurring peptide agonist, dynorphin A, is analgesic in the absence of dysphoria and psychosis, indicating that the therapeutic effects of kappa opioid agonists may be separated from their side effects. As part of our effort to discover kappa opioid receptor analgesics lacking side effects, we designed and constructed two mu/kappa chimeric receptors, composed primarily of amino acid residues derived from the mu opioid receptor, that were expected to bind dynorphin A with high affinity. In one, extracellular loop 2 and transmembrane domain 4 were derived from the kappa opioid receptor and in the other, only extracellular loop 2 was derived from the kappa opioid receptor. Most competitors of [(3)H]diprenorphine binding from a variety of structural classes bound to the chimeras with affinities similar to those with which they bound to the mu opioid receptor. In contrast, dynorphin A analogs bound to the chimeras with affinities similar to those with which they bound to the kappa opioid receptor. Pharmacological characterization of [(35)S]GTPgammaS binding mediated by the chimera with extracellular loop 2 derived from the kappa opioid receptor showed that it behaved as if it were mu opioid receptor with high affinity for dynorphin A analogs. These chimeras may be useful in identifying novel kappa receptor agonists that bind to the second extracellular loop of the receptor and share the desirable therapeutic profile of dynorphin A.
AuthorsRobert N DeHaven, Erik Mansson, Jeffrey D Daubert, Joel A Cassel
JournalCurrent topics in medicinal chemistry (Curr Top Med Chem) Vol. 5 Issue 3 Pg. 303-13 ( 2005) ISSN: 1568-0266 [Print] United Arab Emirates
PMID15857313 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • Recombinant Fusion Proteins
  • Diprenorphine
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Dynorphins
Topics
  • Amino Acid Sequence
  • Binding, Competitive (drug effects)
  • Diprenorphine (metabolism, pharmacology)
  • Dynorphins (metabolism)
  • Guanosine 5'-O-(3-Thiotriphosphate) (metabolism, pharmacology)
  • Humans
  • Molecular Sequence Data
  • Receptors, Opioid, kappa (genetics, metabolism)
  • Receptors, Opioid, mu (genetics, metabolism)
  • Recombinant Fusion Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: